Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters

The new predominant circulating SARS-CoV-2 variant, Omicron, can robustly escape current vaccines and neutralizing antibodies. Although Omicron has been reported to have milder replication and disease manifestations than some earlier variants, its pathogenicity in different age groups has not been w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Lunzhi, Zhu, Huachen, Chen, Peiwen, Zhou, Ming, Ma, Jian, Liu, Xuan, Wu, Kun, Chen, Rirong, Liu, Qiwei, Yu, Huan, Li, Lifeng, Wang, Jia, Zhang, Yali, Ge, Shengxiang, Yuan, Quan, Tang, Qiyi, Cheng, Tong, Guan, Yi, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579545/
https://www.ncbi.nlm.nih.gov/pubmed/36258005
http://dx.doi.org/10.1038/s41423-022-00923-9

Ejemplares similares

Ejemplares similares